Hesperetin

Identification

Generic Name
Hesperetin
DrugBank Accession Number
DB01094
Background

Hesperetin belongs to the flavanone class of flavonoids. Hesperetin, in the form of its glycoside hesperidin, is the predominant flavonoid in lemons and oranges.

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 302.2788
Monoisotopic: 302.07903818
Chemical Formula
C16H14O6
Synonyms
  • (−)-(S)-hesperetin
  • (−)-hesperetin
  • (S)-2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one
  • 3',5,7-Trihydroxy-4'-methoxyflavanone
  • Hesperitin
External IDs
  • FEMA NO. 4313
  • NSC-57654

Pharmacology

Indication

For lowering cholesterol and, possibly, otherwise favorably affecting lipids. In vitro research also suggests the possibility that hesperetin might have some anticancer effects and that it might have some anti-aromatase activity, as well as activity again.

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Hesperetin is a cholesterol lowering flavanoid found in a number of citrus juices. It appears to reduce cholesteryl ester mass and inhibit apoB secretion by up to 80%. Hesperetin may have antioxidant, anti-inflammatory, anti-allergic, hypolipidemic, vasoprotective and anticarcinogenic actions.

Mechanism of action

Hesperetin reduces or inhibits the activity of acyl-coenzyme A:cholesterol acyltransferase genes (ACAT1 and ACAT2) and it reduces microsomal triglyceride transfer protein (MTP) activity. Hesperetin also seems to upregulate the LDL receptor. This leads to the reduced assembly and secretion of apoB-containing lipoproteins and enhanced reuptake of those lipoproteins, thereby lowering cholesterol levels.

TargetActionsOrganism
AMicrosomal triglyceride transfer protein large subunit
antagonist
Humans
ASterol O-acyltransferase 1
inhibitor
Humans
USex hormone-binding globulinNot AvailableHumans
USterol O-acyltransferase 2
inhibitor
Humans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Hover over products below to view reaction partners

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbametapirThe serum concentration of Hesperetin can be increased when it is combined with Abametapir.
AbataceptThe metabolism of Hesperetin can be increased when combined with Abatacept.
AbemaciclibHesperetin may decrease the excretion rate of Abemaciclib which could result in a higher serum level.
AbirateroneThe serum concentration of Hesperetin can be increased when it is combined with Abiraterone.
AcenocoumarolThe metabolism of Acenocoumarol can be decreased when combined with Hesperetin.
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as 4'-o-methylated flavonoids. These are flavonoids with methoxy groups attached to the C4' atom of the flavonoid backbone.
Kingdom
Organic compounds
Super Class
Phenylpropanoids and polyketides
Class
Flavonoids
Sub Class
O-methylated flavonoids
Direct Parent
4'-O-methylated flavonoids
Alternative Parents
3'-hydroxyflavonoids / 5-hydroxyflavonoids / 7-hydroxyflavonoids / Flavanones / Chromones / Methoxyphenols / Methoxybenzenes / Aryl alkyl ketones / Anisoles / Phenoxy compounds
show 7 more
Substituents
1-benzopyran / 1-hydroxy-2-unsubstituted benzenoid / 1-hydroxy-4-unsubstituted benzenoid / 3'-hydroxyflavonoid / 4p-methoxyflavonoid-skeleton / 5-hydroxyflavonoid / 7-hydroxyflavonoid / Alkyl aryl ether / Anisole / Aromatic heteropolycyclic compound
show 24 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
3'-hydroxyflavanones, trihydroxyflavanone, monomethoxyflavanone (CHEBI:28230) / flavanones (C01709) / Flavanones (LMPK12140003)
Affected organisms
  • Humans and other mammals

Chemical Identifiers

UNII
Q9Q3D557F1
CAS number
520-33-2
InChI Key
AIONOLUJZLIMTK-AWEZNQCLSA-N
InChI
InChI=1S/C16H14O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-6,14,17-19H,7H2,1H3/t14-/m0/s1
IUPAC Name
(2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one
SMILES
COC1=C(O)C=C(C=C1)[C@@H]1CC(=O)C2=C(O)C=C(O)C=C2O1

References

General References
Not Available
Human Metabolome Database
HMDB0005782
KEGG Compound
C01709
PubChem Compound
72281
PubChem Substance
46507998
ChemSpider
65234
BindingDB
23418
RxNav
1314255
ChEBI
28230
ChEMBL
CHEMBL399121
ZINC
ZINC000000039092
Therapeutic Targets Database
DAP001306
PharmGKB
PA164742902
PDBe Ligand
6JP
PDRhealth
PDRhealth Drug Page
Wikipedia
Hesperetin
PDB Entries
5jdc / 7pou

Clinical Trials

Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
PhaseStatusPurposeConditionsCount
0CompletedBasic ScienceBlood Glucose Fluctuations / Hunger1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)227.5 °CPhysProp
water solubility273 mg/LNot Available
logP2.60PERRISSOUD,D & TESTA,B (1986)
Predicted Properties
PropertyValueSource
Water Solubility0.138 mg/mLALOGPS
logP2.52ALOGPS
logP2.68Chemaxon
logS-3.3ALOGPS
pKa (Strongest Acidic)7.86Chemaxon
pKa (Strongest Basic)-4.6Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count6Chemaxon
Hydrogen Donor Count3Chemaxon
Polar Surface Area96.22 Å2Chemaxon
Rotatable Bond Count2Chemaxon
Refractivity77.75 m3·mol-1Chemaxon
Polarizability29.3 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9511
Blood Brain Barrier-0.6591
Caco-2 permeable+0.8286
P-glycoprotein substrateSubstrate0.6682
P-glycoprotein inhibitor INon-inhibitor0.743
P-glycoprotein inhibitor IIInhibitor0.5576
Renal organic cation transporterNon-inhibitor0.8866
CYP450 2C9 substrateNon-substrate0.7059
CYP450 2D6 substrateNon-substrate0.863
CYP450 3A4 substrateNon-substrate0.5067
CYP450 1A2 substrateInhibitor0.9106
CYP450 2C9 inhibitorInhibitor0.8949
CYP450 2D6 inhibitorInhibitor0.651
CYP450 2C19 inhibitorInhibitor0.8994
CYP450 3A4 inhibitorInhibitor0.7959
CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.7998
Ames testNon AMES toxic0.8777
CarcinogenicityNon-carcinogens0.9483
BiodegradationNot ready biodegradable0.8978
Rat acute toxicity3.1455 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9747
hERG inhibition (predictor II)Non-inhibitor0.8574
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-00di-0792000000-043d1ca82d4702349341
MS/MS Spectrum - ESI-TOF 10V, NegativeLC-MS/MSsplash10-0udi-0009000000-da94c45c0a6bde515ea3
MS/MS Spectrum - ESI-TOF 20V, NegativeLC-MS/MSsplash10-0udi-0169000000-5d9b7fba914d229018a6
MS/MS Spectrum - ESI-TOF 40V, NegativeLC-MS/MSsplash10-053i-0920000000-b6ab2fed21176a341b28
MS/MS Spectrum - ESI-TOF , NegativeLC-MS/MSsplash10-0udi-0009000000-b833c4c244a2461530ec
MS/MS Spectrum - ESI-TOF 10V, NegativeLC-MS/MSsplash10-0udi-0009000000-32f8b49c4bc1df10782a
MS/MS Spectrum - ESI-TOF 30V, NegativeLC-MS/MSsplash10-0iki-0930000000-20176d350f94ae4a84ed
LC-MS/MS Spectrum - LC-ESI-qTof , PositiveLC-MS/MSsplash10-0udi-2910000000-54a5cf5acd3ca156389e
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-0udi-0009000000-2a5462077f9208908972
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-0udi-0139000000-0c743a741d25379011aa
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-0w2i-0961000000-8406f0210238c955e23e
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-0gw0-0920000000-b833f9a80eb4ea8d3b13
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-052r-0910000000-943c442894f2e6d36fe3
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-0zfr-0925000000-20d9733844b315a5aac1
MS/MS Spectrum - Linear Ion Trap , negativeLC-MS/MSsplash10-0f7c-0092000000-df166f951c1d37996e32
MS/MS Spectrum - Linear Ion Trap , negativeLC-MS/MSsplash10-0f79-0092000000-28f5918da43818b380bf
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0udi-0009000000-fda4f743655d07e229dd
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0ufr-0906000000-4ff368578ae1225967b0
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0ufr-0900000000-aaca372b112b1730d913
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0udi-0900000000-8857224e3cadbbf71a7d
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0udi-0900000000-4507636d98e7b6ebd382
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-004i-0910000000-075f5279e98a14a60a55
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-004i-0910000000-1d9d4c851e8b474cffbe
MS/MS Spectrum - , positiveLC-MS/MSsplash10-0udi-2910000000-54a5cf5acd3ca156389e
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0udi-0019000000-e07b61ebe46236786478
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0udi-0009000000-f8cc10193f09880040d5
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0f92-0901000000-c42a79acd0b49cbcf556
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0ufr-0910000000-5389e7bfd390fadca1d7
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0pdi-2690000000-6501ec46d4a09cb967bd
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-004j-0790000000-c2d03b0f1773af5b8c7e
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-186.7378311
predicted
DarkChem Lite v0.1.0
[M-H]-169.4228882
predicted
DarkChem Standard v0.1.0
[M-H]-186.6873311
predicted
DarkChem Lite v0.1.0
[M-H]-186.6053311
predicted
DarkChem Lite v0.1.0
[M-H]-168.50514
predicted
DeepCCS 1.0 (2019)
[M+H]+190.3248311
predicted
DarkChem Lite v0.1.0
[M+H]+175.3408569
predicted
DarkChem Standard v0.1.0
[M+H]+188.3213311
predicted
DarkChem Lite v0.1.0
[M+H]+188.8842311
predicted
DarkChem Lite v0.1.0
[M+H]+170.86314
predicted
DeepCCS 1.0 (2019)
[M+Na]+187.8313311
predicted
DarkChem Lite v0.1.0
[M+Na]+174.7470478
predicted
DarkChem Standard v0.1.0
[M+Na]+187.7043311
predicted
DarkChem Lite v0.1.0
[M+Na]+187.6931311
predicted
DarkChem Lite v0.1.0
[M+Na]+177.7159
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Yes
Actions
Antagonist
General Function
Protein heterodimerization activity
Specific Function
Catalyzes the transport of triglyceride, cholesteryl ester, and phospholipid between phospholipid surfaces (PubMed:23475612, PubMed:8939939, PubMed:26224785, PubMed:25108285, PubMed:22236406). Requ...
Gene Name
MTTP
Uniprot ID
P55157
Uniprot Name
Microsomal triglyceride transfer protein large subunit
Molecular Weight
99350.255 Da
References
  1. Wilcox LJ, Borradaile NM, de Dreu LE, Huff MW: Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. J Lipid Res. 2001 May;42(5):725-34. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
Yes
Actions
Inhibitor
General Function
Sterol o-acyltransferase activity
Specific Function
Catalyzes the formation of fatty acid-cholesterol esters, which are less soluble in membranes than cholesterol. Plays a role in lipoprotein assembly and dietary cholesterol absorption. In addition ...
Gene Name
SOAT1
Uniprot ID
P35610
Uniprot Name
Sterol O-acyltransferase 1
Molecular Weight
64733.975 Da
References
  1. Wilcox LJ, Borradaile NM, de Dreu LE, Huff MW: Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. J Lipid Res. 2001 May;42(5):725-34. [Article]
  2. Chung MY, Rho MC, Ko JS, Ryu SY, Jeune KH, Kim K, Lee HS, Kim YK: In vitro inhibition of diacylglycerol acyltransferase by prenylflavonoids from Sophora flavescens. Planta Med. 2004 Mar;70(3):258-60. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Androgen binding
Specific Function
Functions as an androgen transport protein, but may also be involved in receptor mediated processes. Each dimer binds one molecule of steroid. Specific for 5-alpha-dihydrotestosterone, testosterone...
Gene Name
SHBG
Uniprot ID
P04278
Uniprot Name
Sex hormone-binding globulin
Molecular Weight
43778.755 Da
References
  1. Hong H, Branham WS, Ng HW, Moland CL, Dial SL, Fang H, Perkins R, Sheehan D, Tong W: Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and alpha-fetoprotein. Toxicol Sci. 2015 Feb;143(2):333-48. doi: 10.1093/toxsci/kfu231. Epub 2014 Oct 27. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Inhibitor
General Function
Transferase activity, transferring acyl groups
Specific Function
Plays a role in lipoprotein assembly and dietary cholesterol absorption. In addition to its acyltransferase activity, it may act as a ligase. May provide cholesteryl esters for lipoprotein secretio...
Gene Name
SOAT2
Uniprot ID
O75908
Uniprot Name
Sterol O-acyltransferase 2
Molecular Weight
59895.735 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Enzymes

Details
1. Cytochrome P450 1A2
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Substrate
General Function
Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
Specific Function
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally un...
Gene Name
CYP1A2
Uniprot ID
P05177
Uniprot Name
Cytochrome P450 1A2
Molecular Weight
58293.76 Da
References
  1. Breinholt VM, Offord EA, Brouwer C, Nielsen SE, Brosen K, Friedberg T: In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids. Food Chem Toxicol. 2002 May;40(5):609-16. [Article]

Transporters

Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Inhibitor
General Function
Xenobiotic-transporting atpase activity
Specific Function
High-capacity urate exporter functioning in both renal and extrarenal urate excretion. Plays a role in porphyrin homeostasis as it is able to mediates the export of protoporhyrin IX (PPIX) both fro...
Gene Name
ABCG2
Uniprot ID
Q9UNQ0
Uniprot Name
ATP-binding cassette sub-family G member 2
Molecular Weight
72313.47 Da
References
  1. Zhang S, Yang X, Morris ME: Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol Pharmacol. 2004 May;65(5):1208-16. [Article]
  2. Imai Y, Tsukahara S, Asada S, Sugimoto Y: Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res. 2004 Jun 15;64(12):4346-52. [Article]

Drug created at June 13, 2005 13:24 / Updated at May 07, 2021 21:22